Medical Training AIMetabolic Disorders and Insulin Resistance
You'll be able to recognize, work up, and manage insulin resistance, metabolic syndrome, and NAFLD in patients presenting with weight-related metabolic dysfunction.
What this track covers
This track covers the pathophysiology of insulin resistance and glucose homeostasis, the diagnostic criteria for metabolic syndrome and NAFLD, and the lifestyle and pharmacologic approaches used to manage them. It's built for clinicians who manage patients with obesity, prediabetes, or abnormal liver enzymes and need a structured way to connect the underlying physiology to day-to-day treatment decisions.
What you will practice
- Interpreting fasting glucose, insulin, HbA1c, and lipid panels to identify metabolic syndrome
- Distinguishing NAFLD from other causes of elevated liver enzymes
- Sequencing lifestyle intervention versus pharmacotherapy for insulin resistance
- Counseling patients on the role of GLP-1 agonists within a broader metabolic treatment plan
- Building a longitudinal monitoring plan for patients with multiple metabolic risk factors
Simulator scenario
A patient with central obesity, elevated fasting glucose, and abnormal liver enzymes presents for a routine visit, requiring the clinician to work through diagnosis and an initial management plan for suspected metabolic syndrome and NAFLD.
Board question topics
- Diagnostic criteria for metabolic syndrome
- Insulin resistance pathophysiology
- NAFLD evaluation and workup
- Pharmacotherapy options for metabolic dysfunction
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free